STAT3 and ovarian carcinoma: In this study, we show a similar up-regulation of activated JAK2/STAT3 pathway, and concomitant significant increase in the expression of CSC-like markers in HEY and TOV21G ovarian cancer cell lines in response to paclitaxel treatment in vitro.